Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
06/2000
06/13/2000US6074625 Using complex of boron isotope
06/13/2000CA2206164C Viscous liquid conditioning topical germicides
06/13/2000CA2125667C Fluorocarbon aerosol medicaments
06/13/2000CA2014847C Process for the preparation of an antimicrobial particulate product, antimicrobial product thus obtained and its use
06/13/2000CA1341022C Prepro-lhrh c-terminal peptide
06/09/2000CA2290711A1 Methods for diagnosing a form of ataxia and compounds for use in the method
06/08/2000WO2000033079A1 Nanoparticles with polymer shells
06/08/2000WO2000032815A1 Molecular conjugate to promote homologous genetic recombination
06/08/2000WO2000032772A2 Erythropoietic compounds
06/08/2000WO2000032764A1 New oligomeric conjugates liable to transfer biological molecules into cells
06/08/2000WO2000032639A1 Novel alkanolamide-free thickening latex
06/08/2000WO2000032635A2 Tumor specific human monoclonal antibodies and methods of use
06/08/2000WO2000032626A1 Methods of using epitope peptides of human pathogens
06/08/2000WO2000032556A1 Derivatives of (-)-venlafaxine and methods of preparing and using the same
06/08/2000WO2000032555A1 Derivatives of (+)-venlafaxine and methods of preparing and using the same
06/08/2000WO2000032307A1 Preparation of multiwall polymeric microcapsules from hydrophilic polymers
06/08/2000WO2000032255A1 Polymeric coatings with controlled delivery of active agents
06/08/2000WO2000032239A1 Hapten-carrier conjugates for treating and preventing nicotine addiction
06/08/2000WO2000032238A1 Stent having drug crystals thereon
06/08/2000WO2000032237A1 Pharmaceutical composition comprising an anti-cancer agent and at least a peptide
06/08/2000WO2000032236A1 Peptides carrying substances across the blood brain barrier
06/08/2000WO2000032235A1 Transport system conjugate
06/08/2000WO2000032234A1 Topical compositions comprising ascomycins
06/08/2000WO2000032233A2 Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith
06/08/2000WO2000032230A1 Immunoglobulin preparations
06/08/2000WO2000032227A2 Ordered molecular presentation of antigens, method of preparation and use
06/08/2000WO2000032219A1 A pharmaceutical composition comprising cyclosporin in a lipid carrier
06/08/2000WO2000032218A1 Controlled release formulation comprising gnrh-ii
06/08/2000WO2000032214A1 Preventives for hepatopathy
06/08/2000WO2000032205A1 Immunomodulatory methods using carbohydrate antigens
06/08/2000WO2000032191A1 New pharmaceutical composition and the process for its preparation
06/08/2000WO2000032186A2 Stabilized injectable pharmaceutical compositions containing taxoid anti-neoplastic agents
06/08/2000WO2000032174A2 Pharmaceutical combination preparations of carvedilol and hydrochlorothiazide
06/08/2000WO2000032173A1 Improved dissolution of triprolidine hydrochloride
06/08/2000WO2000032172A1 An oral formulation for gastrointestinal drug delivery
06/08/2000WO2000032171A2 Autoahesive oral transmucosal delivery dosage form
06/08/2000WO2000032170A1 Preparation of dry compositions soluble in the presence of water and avoiding maillard reaction in dry state and uses
06/08/2000WO2000016752A3 Transdermal devices comprising essential oils for aromatherapy
06/08/2000WO2000015245A3 Stable liquid formulations of botulinum toxin
06/08/2000WO2000009652A3 Method for the preparation of oxide microcapsules loaded with functional molecules and the products obtained thereof
06/08/2000WO2000009086A3 Protected one-vial formulation for nucleic acid molecules, methods of making the same by in-line mixing, and related products and methods
06/08/2000WO2000007629A3 Peg-urate oxidase conjugates and use thereof
06/08/2000WO1999065452B1 Hydrogels of water soluble polymers crosslinked by protein domains
06/08/2000WO1999063934A3 Antimicrobial alcohol gel pre-operative skin-preparation delivery systems
06/08/2000WO1999061062A9 Cyclodextrin complexes
06/08/2000WO1999024076A9 Salicylate derivatized therapeutic and diagnostic agents
06/08/2000DE19856052A1 Konjugat zur Anreicherung in neuronalen Zellen Conjugate to accumulate in neuronal cells
06/08/2000DE19854446A1 Use of hyperforin for treating cancer, or in topical compositions optionally together with hypericin for treating e.g. inflammatory skin disease, skin aging or bacterial skin infections
06/08/2000CA2566516A1 Psca: prostate stem cell antigen and uses thereof
06/08/2000CA2354183A1 Ordered molecular presentation of antigens, method of preparation and use
06/08/2000CA2353798A1 Controlled release formulation comprising gnrh-ii
06/08/2000CA2353703A1 Tumor specific human monoclonal antibodies and methods of use
06/08/2000CA2353606A1 Stent having drug crystals thereon
06/08/2000CA2353502A1 Immunomodulatory methods using carbohydrate antigens
06/08/2000CA2352555A1 Transport system conjugate
06/08/2000CA2352538A1 Erythropoietic compounds
06/08/2000CA2352525A1 Agent protective against hepatopathy
06/08/2000CA2352491A1 Peptides carrying substances across the blood brain barrier
06/08/2000CA2352388A1 A pharmaceutical composition comprising cyclosporin in a lipid carrier
06/08/2000CA2352321A1 Derivatives of (+)-venlafaxine and methods of preparing and using the same
06/08/2000CA2352134A1 Pharmaceutical composition comprising an anti-cancer agent and at least a peptide
06/08/2000CA2348823A1 New oligomeric conjugates liable to transfer biological molecules into cells
06/07/2000EP1005870A2 Therapeutic application of chimeric antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
06/07/2000EP1005863A1 Controlled-release dosage forms comprising a short acting hypnotic or a salt thereof
06/07/2000EP1005860A1 Non-chlorofluorocarbon aerosol formulations
06/07/2000EP1005494A1 High avidity polyvalent and polyspecific reagents
06/07/2000EP1005485A1 Novel pulmonary surfactants and therapeutic uses, including pulmonary lavage
06/07/2000EP1005377A2 Receptor-mediated gene delivery using bacteriophage vectors
06/07/2000EP1005373A1 Modified polypeptides with high activity and reduced allergenicity
06/07/2000EP1005372A1 Anti-cd40l immunotoxins for the treatment of diseases
06/07/2000EP1005368A1 USE OF NUCLEIC ACIDS CONTAINING UNMETHYLATED CpG DINUCLEOTIDE AS AN ADJUVANT
06/07/2000EP1005367A2 Vaccines containing bordetella pertussis antigen
06/07/2000EP1005364A1 Method of protecting against chronic infections
06/07/2000EP1005356A1 Novel antibacterial agents
06/07/2000EP1005351A1 An aqueous metal bicarbonate solution and method of use
06/07/2000EP1005346A2 Solutions containing azasteroids
06/07/2000EP1005339A1 Carotenoid formulation
06/07/2000EP1005335A1 Process for preparing a reactive pharmaceutical product for the detection of gastrointestinal disorder caused by bacteria in the gastrointestinal superior tract
06/07/2000EP1005330A1 Methods and compositions for targeting compounds to muscle
06/07/2000EP1005329A1 Rapidly disintegrating methylcellulose tablets
06/07/2000EP1005327A1 Targeted liposomal constructs for diagnostic and therapeutic uses
06/07/2000EP1005326A1 Method for producing liposomes with increased percent of compound encapsulated
06/07/2000EP1005324A1 Compositions for delivery of biological agents and methods for the preparation thereof
06/07/2000EP0773025B1 New stable galenic formulations containing an acid-labile benzimidazol compound, and production process
06/07/2000EP0633783B1 Rapamycin formulation for iv injection
06/07/2000CN1255944A Modified arginine deiminase
06/07/2000CN1255861A Multivalent vaccine compsn. with mixed carrier
06/07/2000CN1255852A Novel method and compsns. for drug feeding of taxad alkyl compounds
06/07/2000CN1255849A Medical compsns.
06/07/2000CN1255847A Cosmetics
06/07/2000CN1255829A Stable ascorbic acid inorganic salt liquid compsns., its prepn. method and applications
06/07/2000CN1255371A Hypolipemic medicine for lossing weight and its preparing process
06/07/2000CN1255335A Cathartic
06/07/2000CN1255331A Hollow prosomatic liposome, its preparing process and clinical application of its encapsulated matter
06/07/2000CN1255307A Process for preparing plant tar-reducing agent and its usage
06/07/2000CN1053117C Processes for prepn. of compsns. used in treatment of kaposi
06/06/2000US6072100 Extrudable compositions for topical or transdermal drug delivery
06/06/2000US6072041 Single chain fv molecule directed against a transcytotic receptor covalently linked to a therapeutic protein; to deliver therapy to the other side of a cell
06/06/2000US6072040 Stabilized conjugates of uncomplexed subunits of multimeric proteins
06/06/2000US6072038 Conjugates of texaphyrins
1 ... 1377 1378 1379 1380 1381 1382 1383 1384 1385 1386 1387 1388 1389 1390 1391 1392 1393 1394 1395 1396 1397 ... 1712